Misonix, Inc, together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States, the Americas, Europe, Middle East, Asia Pacific, Africa, and internationally. The company offers BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells.
Read More…
Industry, Sector and Symbol
Industry Laboratory apparatus & furniture
Sub-IndustryN/A
SectorComputer and Technology
Phone631-694-9555
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$38.85 million
Profitability
Miscellaneous
Employees118
Next Earnings Date11/14/2019 (Estimated)
OptionableNot Optionable
Misonix (NASDAQ:MSON) Frequently Asked Questions
What is Misonix's stock symbol?
Misonix trades on the NASDAQ under the ticker symbol "MSON."
How were Misonix's earnings last quarter?
Misonix, Inc. (NASDAQ:MSON) released its quarterly earnings results on Wednesday, August, 14th. The medical equipment provider reported ($0.11) earnings per share (EPS) for the quarter. The medical equipment provider earned $9.75 million during the quarter. Misonix had a negative return on equity of 25.99% and a negative net margin of 19.01%. View Misonix's Earnings History.
When is Misonix's next earnings date?
What price target have analysts set for MSON?
2 equities research analysts have issued 12-month target prices for Misonix's stock. Their predictions range from $27.00 to $30.00. On average, they anticipate Misonix's share price to reach $28.50 in the next year. This suggests a possible upside of 65.3% from the stock's current price. View Analyst Price Targets for Misonix.
What is the consensus analysts' recommendation for Misonix?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Misonix in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Misonix.
Has Misonix been receiving favorable news coverage?
News headlines about MSON stock have trended somewhat negative on Wednesday, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Misonix earned a news sentiment score of -1.2 on InfoTrie's scale. They also gave media headlines about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Misonix.
Are investors shorting Misonix?
Misonix saw a decline in short interest in the month of September. As of September 15th, there was short interest totalling 384,700 shares, a decline of 5.5% from the August 15th total of 406,900 shares. Based on an average daily trading volume, of 64,000 shares, the days-to-cover ratio is currently 6.0 days. Approximately 4.8% of the shares of the company are short sold. View Misonix's Current Options Chain.
Who are some of Misonix's key competitors?
Some companies that are related to Misonix include QuinStreet (QNST), Smart Global (SGH), Control4 (CTRL), CEVA (CEVA), Agilysys (AGYS), Emis Group (EMIS), TechTarget (TTGT), Forrester Research (FORR), Ribbon Communications (RBBN), Simulations Plus (SLP), IQE (IQEPF), Onespan (OSPN), Cohu (COHU), Tucows (TCX) and Axcelis Technologies (ACLS).
What other stocks do shareholders of Misonix own?
Who are Misonix's key executives?
Misonix's management team includes the folowing people:
- Mr. Stavros George Vizirgianakis, Pres, CEO & Director (Age 49)
- Mr. Joseph P. Dwyer, CFO, Treasurer & Sec. (Age 63)
- Mr. Robert Scott Ludecker, Sr. VP of Global Sales & Marketing (Age 52)
- Ms. Sharon W. Klugewicz, Chief Operating Officer (Age 51)
- Mr. John J. Salerno, VP of Quality and Regulatory Affairs & Chief Compliance Officer (Age 64)
How do I buy shares of Misonix?
Shares of MSON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Misonix's stock price today?
One share of MSON stock can currently be purchased for approximately $17.24.
How big of a company is Misonix?
What is Misonix's official website?
How can I contact Misonix?
Misonix's mailing address is 1938 NEW HIGHWAY, FARMINGDALE NY, 11735. The medical equipment provider can be reached via phone at 631-694-9555.
MarketBeat Community Rating for Misonix (NASDAQ MSON)
MarketBeat's community ratings are surveys of what our community members think about Misonix and other stocks. Vote "Outperform" if you believe MSON will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MSON will underperform the S&P 500 over the long term. You may vote once every thirty days.
